Mereo BioPharma Group plc (Mereo) (MREO) Social Stream
Mereo Biopharma Group plc (MREO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Mereo Biopharma Group plc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
MREO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Mereo Biopharma Group plc's number of analysts covering the stock is higher than 4.67% of all US stocks.
- In the context of all US stocks, Mereo Biopharma Group plc's upside potential (average analyst target price relative to current price) is greater than 194.56% of them.
- MREO has a greater average analyst price target than 26.9% of Healthcare stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Mereo Biopharma Group plc's variance in analysts' estimates is lower than 66.8% of them.
Is MREO a Buy, Hold or Sell? See the POWR Ratings now!